Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study.
about
Major clinical research advances in gynecologic cancer in 2013Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice.Knowledge of Patients' Human Papillomavirus Status at the Time of Cytologic Review Significantly Affects the Performance of Cervical Cytology in the ATHENA Study.Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data.Computerized delineation of nuclei in liquid-based pap smears stained with immunohistochemical biomarkers.Clinical Implication of p16, Ki-67, and Proliferating Cell Nuclear Antigen Expression in Cervical Neoplasia: Improvement of Diagnostic Accuracy for High-grade Squamous Intraepithelial Lesion and Prediction of Resection Margin Involvement on ConizatiStratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCMComparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial.p16(INK4a)/Ki-67 dual stain cytology for cervical cancer screening in Thika district, Kenya.Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern ThailandRelevance of HPV Screening for Triaging Equivocal Cytology Findings in the Pap II-p, Pap III and Pap IIID Groups - Results of Two Long-Term StudiesKeratoacanthoma of the Lip: Activation of the mTOR Pathway, Tumor Suppressor Proteins, and Tumor Senescencep16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive WomenDiscovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.Immunocytochemical study of TOP2A and Ki-67 in cervical smears from women under routine gynecological careEvaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.A polycomb-mediated epigenetic field defect precedes invasive cervical carcinomaRole of p16/INK4a and Ki-67 as specific biomarkers for cervical intraepithelial neoplasia: An institutional study.p16/Ki-67 co-expression associates high risk human papillomavirus persistence and cervical histopathology: a 3-year cohort study in China.The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments.Anal intraepithelial neoplasia: a single centre 19 year review.A systematic review of p16/Ki-67 immuno-testing for triage of low grade cervical cytology.Prophylactic HPV vaccination: past, present, and future.Management of high-risk HPV-positive women for detection of cervical (pre)cancer.p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck region.Molecular approaches for HPV genotyping and HPV-DNA physical status.Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer.[Indications for p16/Ki-67 in cervical cytology].Performance of a new HPV and biomarker assay in the management of hrHPV positive women: Subanalysis of the ongoing multicenter TRACE clinical trial (n > 6,000) to evaluate POU4F3 methylation as a potential biomarker of cervical precancer and cancer.Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN.Detection of Papillomavirus Gene Expression Patterns in Tissue Sections.Viral infections associated with oral cancers and diseases in the context of HIV: a workshop report.p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population.Triage of LSIL/ASC-US with p16/Ki-67 dual staining and human papillomavirus testing: a 2-year prospective study.Sensitivity of APTIMA HPV E6/E7 mRNA test in comparison with hybrid capture 2 HPV DNA test for detection of high risk oncogenic human papillomavirus in 396 biopsy confirmed cervical cancers.[Who performs gynecological cytology and how?].The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients.Interpretation of p16(INK4a) /Ki-67 dual immunostaining for the triage of human papillomavirus-positive women by experts and nonexperts in cervical cytology.mRNA biomarker detection in liquid-based cytology: a new approach in the prevention of cervical cancer.Interobserver reproducibility and accuracy of p16/Ki-67 dual-stain cytology in cervical cancer screening.
P2860
Q24562146-70531CDE-7E0B-4319-BA1A-FAD5C26C1F63Q30239987-7AC14D61-C44E-4B7F-A09B-F241244B8F4DQ30276085-B5E0A6CC-6441-4C56-972A-E70853469B69Q30863996-EF92492F-3C88-4B75-A9CE-843E6E3EB3BAQ34301277-D08118FA-DEA6-481C-9F3C-F1CE1A1DD66CQ35261428-6DBB5645-0112-49B4-934C-2A2A73668D46Q35811067-EB195930-6E59-47BF-9EF1-FD05346086C0Q35870574-9702231C-548B-4AB1-9AC0-9A84999D17E4Q35936549-2E49184F-8B6A-4CD9-B759-306D3B3B0E7FQ36060165-8FF1862E-52E7-4613-8D4F-BD1E234DBD2FQ36240034-AF0F4471-6B36-4685-9A0F-3BAF96F6750EQ36255926-1F95D9C1-ED30-4A15-8011-1A16156682F3Q36361863-19BAC102-9C37-494E-865F-60B2D8394A0DQ36668105-2161E7E7-B5DC-4A40-ADB9-B5714D956B9EQ36895454-89B5CABE-3BA6-421E-9A98-A2B62880D249Q37225246-CCF496A1-222D-43B2-9708-7D0753C2A58BQ37641741-A31D5656-30CB-430B-841B-4ED15E36CFFBQ37658686-5C0C9D0D-7B79-40AD-A1F3-2BBD6B6D2E39Q37662140-EA29DC7C-486B-452A-9325-EB89ABFB445FQ38205174-C0887D34-B50F-4AFB-89F8-3F742590D4E6Q38216923-CDC05003-D4CD-419B-8916-92C600B5D823Q38248178-8EB8D98A-C79D-4AFE-A7D2-4646A61C6929Q38597567-E52C7A39-A066-4808-A70F-62BD8E1C162DQ38837737-D2A23283-6B7B-4BEC-8FF4-53AF56FA292CQ38967902-5CA9417D-A39B-4A72-A67E-9AE05F6B2B61Q39120200-D1BC8E27-E694-42B8-B8CA-8048A8FB2E41Q40202976-25558B6F-C6A1-428B-AE98-B491DCB0DAFEQ40373166-590D5ADC-15A6-45F7-85E9-CC1195D6312EQ40440825-CED078FF-1AC5-479F-B574-56F5DBD67D91Q40525853-AA1CDC8B-76EA-4A2E-8F70-200D3589A834Q40684530-AF2B7355-3CC6-4A5B-B698-21A0D3B85EADQ40701192-40A9C9A2-933C-4025-8B20-F2389AD2D558Q40767169-32307803-5CF8-42EE-8E27-B0B4B3B7979BQ40771269-69379521-D2CF-46DF-8708-38FEF61EC853Q40861259-9AF5E0E0-5E94-414F-A276-3F38ECBD3FD1Q40954933-1B5C2FA1-B13E-444A-8B51-A9B445388B67Q41140848-8EE6FAE5-5A15-4539-A234-77D704FF06E3Q41585139-5E9AE1E6-05FE-44B6-B019-EB4DE97C8CD9Q42192987-B670E569-3A08-401C-B456-2F5FA3F91E9FQ42199369-BCF170F1-EEB3-41FE-9568-2B8B756BFFCF
P2860
Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Screening for cervical cancer ...... y: results of the PALMS study.
@en
Screening for cervical cancer ...... y: results of the PALMS study.
@nl
type
label
Screening for cervical cancer ...... y: results of the PALMS study.
@en
Screening for cervical cancer ...... y: results of the PALMS study.
@nl
prefLabel
Screening for cervical cancer ...... y: results of the PALMS study.
@en
Screening for cervical cancer ...... y: results of the PALMS study.
@nl
P2093
P2860
P356
P1476
Screening for cervical cancer ...... y: results of the PALMS study.
@en
P2093
Christine Bergeron
Claudio Angeloni
Dietmar Schmidt
Francisco Alameda
Hans Ikenberg
Heinrich H Neumann
Henrik Griesser
Jalil Hariri
Karin Denton
Luis M Puig-Tintore
P2860
P304
P356
10.1093/JNCI/DJT235
P407
P577
2013-10-04T00:00:00Z